89bio, Inc. (ETNB)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

535 MISSION STREET SAN FRANCISCO, CA 94105

89Bio, Inc. operates as a biopharmaceutical company. The Company develops treatments for liver and metabolic disorders. 89Bio serves customers in the State of California.

Data as of 2020-08-01
Market Cap511.971 Million Shares Outstanding16.852 Million Avg 30-day Volume153.399 Thousand
P/E Ratio Dividend Yield EPS-26.91
Price/Sales Price cash flow ratio Price free cash flow ratio-19.4
Book Value4.74 Price to Tangible Book6.14 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.020111
BETA0.501327 52-week High/Low47.2532 / 14.0001 Stddev0.28206
View SEC Filings from ETNB instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 31 7 (0.46%)
Aggregate 13F shares on 03/31/2020: 10.7 Million 8.583 Million
Aggregate 13F shares on 12/31/2019: 10.442 Million 8.402 Million
Percent change: 2.47% 2.16%
Funds creating new positions: 4 1
Funds Adding to an existing position: 15 4
Funds closing out their position: 6 4
Funds reducing their position: 5
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ETNB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ETNB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

493.2 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LONGITUDE CAPITAL PARTNERS III, LLC

LONGITUDE VENTURE PARTNERS III, L.P.

TAMMENOMS BAKKER JULIET

ENRIGHT PATRICK G

  • 10% Owner
2,819,379 2020-07-28 3

DIROCCO DEREK

  • Director
0 2020-07-23 3

GRUNBERG GREGORY

  • Director
  • 10% Owner
2,600,877 2020-07-10 5

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • Director
  • 10% Owner
3,436,214 2020-07-08 3

HAYDEN MICHAEL R

  • Director
3,556 2020-07-01 4

ALTSCHULER STEVEN

  • Director
24,604 2020-06-29 3

NASCHITZ ANAT

  • Director
  • 10% Owner
0 2020-06-22 4

ZOTH LOTA S.

  • Director
0 2020-06-12 2

LE-NGUYEN QUOC SEE REMARKS

  • Officer
0 2020-02-14 2

MANSBACH HARRY H CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-14 2

WAISBOURD RAM COO AND CHIEF BUSINESS OFFICER

  • Officer
0 2020-02-14 2

MARTINS RYAN CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-14 2

PALEKAR ROHAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-02-14 2

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED ADVISORS ISRAEL II LTD

ORBIMED ISRAEL GP II, L.P.

  • Director
  • 10% Owner
4,728,805 2019-11-11 2

KARIV TOMER

PONTIFAX (ISRAEL) V, L.P.

PONTIFAX (CAYMAN) V, L.P.

PONTIFAX (CHINA) V, L.P.

PONTIFAX 5 G.P. L.P.

PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.

PONTIFAX LATE STAGE GP LTD.

PONTIFAX LATE STAGE FUND L.P.

  • Director
  • 10% Owner
1,134,671 2019-11-11 2

KARIV TOMER

PONTIFAX (ISRAEL) V, L.P.

PONTIFAX (CAYMAN) V, L.P.

PONTIFAX (CHINA) V, L.P.

PONTIFAX 5 G.P. L.P.

PONTIFAX MANAGEMENT 4 G.P. (2015) LTD.

  • Director
  • 10% Owner
0 2019-11-08 2

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GRUNBERG GREGORY - Director - > 10% Owner see footnote

2020-07-10 P 109,090 $27.50 a 2,600,877 2,600,877.00 indirect

LONGITUDE CAPITAL PARTNERS III, LLC - > 10% Owner see footnote

LONGITUDE VENTURE PARTNERS III, L.P. - > 10% Owner see footnote

TAMMENOMS BAKKER JULIET - > 10% Owner see footnote

ENRIGHT PATRICK G - > 10% Owner see footnote

2020-07-10 P 109,090 $27.50 a 2,600,877 2,600,877.00 indirect

RA CAPITAL MANAGEMENT, L.P. - Director - > 10% Owner see footnote

RA CAPITAL HEALTHCARE FUND LP - > 10% Owner see footnote

KOLCHINSKY PETER - > 10% Owner see footnote

SHAH RAJEEV M. - > 10% Owner see footnote

2020-07-08 P 275,000 $27.50 a 3,436,214 3,436,214.00 indirect

NASCHITZ ANAT - Director - > 10% Owner see footnote

2020-06-22 A 7,000 a 7,000 0.00 indirect

GRUNBERG GREGORY - Director - > 10% Owner

2020-06-22 A 7,000 a 7,000 0.00 direct

DIROCCO DEREK - Director see footnote

2020-06-22 A 7,000 a 7,000 0.00 indirect

HAYDEN MICHAEL R - Director

2020-06-22 A 7,000 a 7,000 0.00 direct

ALTSCHULER STEVEN - Director

2020-06-22 A 7,000 a 7,000 0.00 direct

ZOTH LOTA S. - Director

2020-06-12 A 20,000 a 20,000 0.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments